Jeryl L. Hilleman, Chief Financial Officer at Intersect ENT, Inc. (XENT), sold 25,666 shares at $35.80 ($919K) on 2018-02-06, disclosed to the SEC on 2018-02-07.
Open-market sale of $919k XENT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.80 | 12,833 | $459K | 50.0% |
| 2 | $35.80 | 12,833 | $459K | 50.0% |
| Total | $35.80 avg | 25,666 | $919K | 100% |
| Filing → |
| SIBN | SELL | 2023-06-20 | $178K | — | Filing → |
| NVCR | SELL | 2022-06-16 | $28K | — | Filing → |
| SIBN | SELL | 2022-06-14 | $27K | — | Filing → |